Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine with nalbuphine PCIA for sleep and pain after cesarean section
ChiCTR2500115366Phase 4Not yet recruiting
- Sponsor
- Nanchong City Central Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in postoperative pain, sleep disorder, anxiety disorder, major depressive disorder (MDD), sponsored by Nanchong City Central Hospital. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painsleep disorderanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2500115366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115366.